Skip to content

Sexual Well-being of Women Undergoing Mastectomy and Reconstruction

Sexual Well-being of Women Undergoing Mastectomy and Reconstruction: a National Survey.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07234461
Enrollment
200
Registered
2025-11-18
Start date
2026-01-21
Completion date
2026-10-01
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastectomy and Breast Reconstruction, Sexual Wellness

Brief summary

The study plans to collect data from patients on sexual well-being after mastectomy and immediate reconstruction by surveys. This data can support preoperative patient counselling and the prevention and care of adverse effects of cancer treatments. Specific subpopulations of mastectomy women showing severe sexual impairment can be outlined; they may benefit from lifestyle changes and intervention strategies (intravaginal use of diazepam, local hyaluronic acid, intravaginal use of spermidine, pelvic floor gymnastic and physiotherapy). Our goal is to improve quality of life of breast cancer patients.

Interventions

OTHERSurvey using a questionnaire.

Questionnaires collecting sociodemographic information and their sexual well-being.

Sponsors

European Institute of Oncology
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing mastectomy for primary breast cancer; * High-risk healthy patients undergoing risk reducing mastectomies; * Unilateral and/or bilateral mastectomies; * If unilateral mastectomy, both patients requiring or not contralateral mammaplasty of the healthy breast; * All reconstructive procedures included (autologous and heterologous reconstructions).

Exclusion criteria

* Patients undergoing breast conservation; * Patients who previously underwent breast cancer treatment, requiring further surgery for local relapse or secondary breast cancers; * Delayed post-mastectomy reconstructions; * Patients not available for e-correspondence.

Design outcomes

Primary

MeasureTime frameDescription
Sexual well-beingEnrollment visitSexual well-being, a multidimensional construct, will be assessed using a combination of validated and non-validated questionnaires. For each outcome score, descriptive statistics will be reported, including mean, standard deviation, median, and interquartile range. Comparisons of mean scores across predefined subgroups-such as type of reconstruction, systemic and local treatments, menopausal status, obesity, and parity-will be conducted using analysis of variance. A p-value \< 0.05 will be considered statistically significant.

Countries

Italy

Contacts

CONTACTFrancesca De Lorenzi, MD
francesca.delorenzi@ieo.it+39 0257489.394

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026